Search
for

    Sort by

    Research 181–210 of 1000+

    1. Recent patent applications for coffee and coffee by‐products as active ingredients in cosmetics International Journal of Cosmetic Science · 2023 · 3 citations
    2. Matriptase: Potent Proteolysis on the Cell Surface Molecular Medicine · 2006 · 165 citations
    3. Minoxidil Use in Dermatology, Side Effects and Recent Patents Recent Patents on Inflammation & Allergy Drug Discovery · 2012 · 152 citations
    4. Natural potent androgens: Lessons from human genetic models Baillière s Clinical Endocrinology and Metabolism · 1998 · 60 citations
    5. Hypervitaminosis A in a Patient With Alopecia Receiving Renal Dialysis Archives of Dermatology · 1979 · 24 citations
    6. Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib Acta Dermato Venereologica · 2020 · 13 citations
    7. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer Journal of Advanced Research · 2024 · 11 citations
    8. Granulation Tissue that Developed after a Minor Trauma in a Psoriatic Patient on Long-term Etretinate Therapy The Journal of Dermatology · 1990 · 10 citations
    9. A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2 Gynecological Endocrinology · 2007 · 9 citations
    10. Hypervitaminosis A in a patient with alopecia receiving renal dialysis Archives of Dermatology · 1979 · 7 citations
    11. Resolution of pseudoainhum with acitretin therapy in a patient with palmoplantar keratoderma and congenital alopecia JAAD case reports · 2019 · 6 citations
    12. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents Recent patents on inflammation & allergy drug discovery · 2020 · 5 citations
    13. Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia-Pacific and Latin America Journal of Dermatology · 2017 · 5 citations
    14. Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study International Journal of Women’s Dermatology · 2024 · 3 citations
    15. Alopecia totalis successfully treated with modified platelet-rich plasma therapy in a patient recalcitrant to traditional treatment modalities Clinical dermatology review · 2021 · 2 citations
    16. Complete hair regrowth in a patient with severe alopecia areata treated with deucravacitinib Clinical and Experimental Dermatology · 2025 · 1 citations
    17. FFA Patient Profile Analysis Based on the Authors’ Observations and a Review of the Literature—An Original Survey Journal of Clinical Medicine · 2025 · 1 citations
    18. The patient outcomes with EGFR-mutated advanced non-small-cell lung cancer receiving aumolertinib as first-line treatment. Journal of Clinical Oncology · 2024 · 1 citations
    19. PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia Journal of the Endocrine Society · 2022 · 1 citations
    20. Chronic Lupus Erythematosus and Systemic Scleroderma Coexistent at the Same Patient ARC Journal of Dermatology · 2018 · 1 citations
    21. Clinical Assessment of the Patient 2011 · 1 citations
    22. A patient with eosinophilia-myalgia syndrome. PubMed · 1990 · 1 citations
    23. Dermatology patient-derived health utility of facial angiofibroma associated with tuberous sclerosis complex Quality of Life Research · 2026
    24. INTERDISCIPLINARY PATIENT PATHWAY FOR ALOPECIA: COORDINATING MEDICAL THERAPY, TRICHOLOGICAL CARE AND VISUAL SUPPORT 2026
    25. Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with <i>AIRE</i> gene mutation (autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy, APECED syndrome) treated with ruxolitinib Clinical and Experimental Dermatology · 2026
    26. Dermatology Patient Support Groups Journal of the Dermatology Nurses’ Association · 2025
    27. A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making Value in Health · 2025
    28. Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment The Journal of Dermatology · 2025
    29. 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials Journal of the American Academy of Dermatology · 2024
    30. LB920 Patient-reported side effects of oral minoxidil in treating female pattern hair-loss Journal of Investigative Dermatology · 2024